Choice and doses of antibacterial agents for cement spacers in treatment of prosthetic joint infections: Review of published studies

Clinical Infectious Diseases

Volumn 55, Issue 11, 2012, Pages 1474-1480

  Iarikov, D ^a   Demian, H ^b   Rubin, D ^c   Alexander, J ^a   Nambiar, S ^a  

^a Center for Drug Evaluation and Research   (United States)

^b CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTIINFECTIVE AGENT; BONE CEMENT; CEFOTAXIME; ERYTHROMYCIN; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

BACTERIAL LOAD; COAGULASE NEGATIVE STAPHYLOCOCCUS; FOLLOW UP; HIP ARTHROPLASTY; HIP PROSTHESIS; HUMAN; INFECTION CONTROL; KNEE ARTHROPLASTY; MEDLINE; PERIPROSTHETIC JOINT INFECTION; PRIORITY JOURNAL; PUBLICATION; REVIEW; STAPHYLOCOCCUS; STUDY DESIGN; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BONE CEMENTS; HUMANS; PROSTHESIS-RELATED INFECTIONS; VANCOMYCIN;

EID: 84869000934     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis735     Document Type: Review

References (48)

1. Leone JM, Hanssen AD. Management of infection at the site of a total knee arthroplasty. J Bone Joint Surg Am 2005; 87:2335-48.
2. Clyburn TA, Cui Q. Antibiotic laden cement: current state of the art. AAOS Now. Available at: http://www.aaos.org/news/bulletin/may07/clinical7.asp.
3. Cui Q, Mihalko WM, Shields JS, Ries M, Saleh KJ. Antibioticimpregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am 2007; 89:871-82.
4. Jacofsky DJ, Hanssen AD. The infected total knee arthroplasty. In: Barrack RL, et al, eds. OKU, Orthopaedic knowledge update. Hip and knee reconstruction 3rd Edition. Rosemont: American Academy of Orthopaedic Surgeons; 2006: 177-83.
5. Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am 2006; 88:2487-500.
6. Jacofsky DJ, Della Valle CJ, Meneghini RM, Sporer SM, Cercek RM. Revision total knee arthroplasty: what the practicing orthopaedic surgeon needs to know. J Bone Joint Surg Am 2010; 92:1282-92.
7. Fitzgerald RH Jr. Infections of hip prostheses and artificial joints. Infect Dis Clin North Am 1989; 3:329-38.
8. Norden C, Nelson JD, Mader JT, Calandra GB. Evaluation of new anti-infective drugs for the treatment of infections of prosthetic hip joints. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992; 15 (Suppl 1):S177-81.
9. Cabrita HB, Croci AT, Camargo OP, Lima AL. Prospective study of the treatment of infected hip arthroplasties with or without the use of an antibiotic-loaded cement spacer. Clinics (Sao Paulo) 2007; 62:99-108.
10. Koo KH, Yang JW, Cho SH, et al. Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty. J Arthroplasty 2001; 16:882-92.
11. Hofmann AA, Goldberg TD, Tanner AM, Cook TM. Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip. J Arthroplasty 2005; 20:874-9.
12. Durbhakula SM, Czajka J, Fuchs MD, Uhl RL. Spacer endoprosthesis for the treatment of infected total hip arthroplasty. J Arthroplasty 2004; 19:760-7.
13. Meek RM, Masri BA, Dunlop D, et al. Patient satisfaction and functional status after treatment of infection at the site of a total knee arthroplasty with use of the PROSTALAC articulating spacer. J Bone Joint Surg Am 2003; 85-A:1888-92.
14. Fehring TK, Odum S, Calton TF, Mason JB. Articulating versus static spacers in revision total knee arthroplasty for sepsis. The Ranawat Award. Clin Orthop Relat Res 2000; 380:9-16.
15. Kurd MF, Ghanem E, Steinbrecher J, Parvizi J. Two-stage exchange knee arthroplasty: does resistance of the infecting organism influence the outcome? Clin Orthop Relat Res 2010; 468:2060-6.
16. Whittaker JP, Warren RE, Jones RS, Gregson PA. Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection? J Bone Joint Surg Br 2009; 91:44-51.
17. Evans RP. Successful treatment of total hip and knee infection with articulating antibiotic components: a modified treatment method. Clin Orthop Relat Res 2004; 427:37-46.
18. Hofmann AA, Goldberg T, Tanner AM, Kurtin SM. Treatment of infected total knee arthroplasty using an articulating spacer: 2- to 12- year experience. Clin Orthop Relat Res 2005; 430:125-31.
19. Mont MA, Waldman BJ, Hungerford DS. Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection: a comparison-group study. J Bone Joint Surg Am 2000; 82-A:1552-7.
20. Emerson RH Jr, Muncie M, Tarbox TR, Higgins LL. Comparison of a static with a mobile spacer in total knee infection. Clin Orthop Relat Res 2002; 404:132-8.
21. Siebel T, Kelm J, Porsch M, Regitz T, Neumann WH. Two-stage exchange of infected knee arthroplasty with an prosthesis-like interim cement spacer. Acta Orthop Belg 2002; 68:150-6.
22. Cuckler JM. The infected total knee: management options. J Arthroplasty 2005; 20(4 Suppl 2):33-6.
23. Romano CL, Romano D, Logoluso N, Meani E. Septic versus aseptic hip revision: how different? J Orthop Traumatol 2010; 11:167-74.
24. Tunney MM, Ramage G, Patrick S, Nixon JR, Murphy PG, Gorman SP. Antimicrobial susceptibility of bacteria isolated from orthopedic implants following revision hip surgery. Antimicrob Agents Chemother 1998; 42:3002-5.
25. Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect 2007; 55:1-7.
26. Hope PG, Kristinsson KG, Norman P, Elson RA. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br 1989; 71:851-5.
27. Anguita-Alonso P, Hanssen AD, Osmon DR, Trampuz A, Steckelberg JMPatel R. High rate of aminoglycoside resistance among staphylococci causing prosthetic joint infection. Clin Orthop Relat Res 2005; 439:43-7.
28. Springer BD, Lee GC, Osmon D, Haidukewych GJ, Hanssen AD, Jacofsky DJ. Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin Orthop Relat Res 2004; 427:47-51.
29. Hsieh PH, Huang KC, Tai CL. Liquid gentamicin in bone cement spacers: in vivo antibiotic release and systemic safety in two-stage revision of infected hip arthroplasty. J Trauma 2009; 66:804-8.
30. Gooding CR, Masri BA, Duncan CP, Greidanus NV, Garbuz DS. Durable infection control and function with the PROSTALAC spacer in two-stage revision for infected knee arthroplasty. Clin Orthop Relat Res 2011; 469:985-93.
31. Jung J, Schmid NV, Kelm J, Schmitt E, Anagnostakos K. Complications after spacer implantation in the treatment of hip joint infections. Int J Med Sci 2009; 6:265-73.
32. Isiklar ZU, Demirors H, Akpinar S, Tandogan RN, Alparslan M. Two-stage treatment of chronic staphylococcal orthopaedic implantrelated infections using vancomycin impregnated PMMA spacer and rifampin containing antibiotic protocol. Bull Hosp Jt Dis 1999; 58:79-85.
33. van Raaij TM, Visser LE, Vulto AG, Verhaar JA. Acute renal failure after local gentamicin treatment in an infected total knee arthroplasty. J Arthroplasty 2002; 17:948-50.
34. Patrick BN, Rivey MP, Allington DR. Acute renal failure associated with vancomycin- and tobramycin-laden cement in total hip arthroplasty. Ann Pharmacother 2006; 40:2037-42.
35. Curtis JM, Sternhagen V, Batts D. Acute renal failure after placement of tobramycin-impregnated bone cement in an infected total knee arthroplasty. Pharmacotherapy 2005; 25:876-80.
36. Dovas S, Liakopoulos V, Papatheodorou L, et al. Acute renal failure after antibiotic-impregnated bone cement treatment of an infected total knee arthroplasty. Clin Nephrol 2008; 69:207-12.
37. Hanssen AD, Spangehl MJ. Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res 2004; 427:79-85.
38. Penner MJ, Masri BA, Duncan CP. Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty 1996; 11:939-44.
39. Penner MJ, Duncan CP, Masri BA. The in vitro elution characteristics of antibiotic-loaded CMW and Palacos-R bone cements. J Arthroplasty 1999; 14:209-14.
40. Masri BA, Campbell DG, Garbuz DS, Duncan CP. Seven specialized exposures for revision hip and knee replacement. Orthop Clin North Am 1998; 29:229-40.
41. Fink B, Vogt S, Reinsch M, Büchner H. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Orthop Relat Res 2011; 469:3141-7.
42. Jamsen E, Stogiannidis I, Malmivaara A, Pajamaki J, Puolakka T, Konttinen YT. Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach. Acta Orthop 2009; 80:67-77.
43. Ha CW. A technique for intraoperative construction of antibiotic spacers. Clin Orthop Relat Res 2006; 445:204-9.
44. Durbhakula SM, Czajka J, Fuchs MD, Uhl RL. Antibiotic-loaded articulating cement spacer in the 2-stage exchange of infected total knee arthroplasty. J Arthroplasty 2004; 19:768-74.
45. Hsu YC, Cheng HC, Ng TP, Chiu KY. Antibiotic-loaded cement articulating spacer for 2-stage reimplantation in infected total knee arthroplasty: a simple and economic method. J Arthroplasty 2007; 22:1060-6.
46. Park SJ, Song EK, Seon JK, Yoon TR, Park GH. Comparison of static and mobile antibiotic-impregnated cement spacers for the treatment of infected total knee arthroplasty. Int Orthop 2010; 34:1181-6.
47. Hart WJ, Jones RS. Two-stage revision of infected total knee replacements using articulating cement spacers and short-term antibiotic therapy. J Bone Joint Surg Br 2006; 88:1011-5.
48. Barrack RL. Rush pin technique for temporary antibiotic-impregnated cement prosthesis for infected total hip arthroplasty. J Arthroplasty 2002; 17:600-3.